vs
Side-by-side financial comparison of Dexcom (DXCM) and Principal Financial Group (PFG). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $750.8M, roughly 1.7× Principal Financial Group). Dexcom runs the higher net margin — 21.2% vs 0.3%, a 21.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 4.0%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -58.3%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Principal Financial GroupPFGEarnings & Financial Report
Principal Financial Group, Inc. (PFG) is an American global financial investment management and insurance company headquartered in Des Moines, Iowa, United States.
DXCM vs PFG — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $750.8M |
| Net Profit | $267.3M | $1.9M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | — |
| Net Margin | 21.2% | 0.3% |
| Revenue YoY | 21.6% | 4.0% |
| Net Profit YoY | 153.6% | 783.0% |
| EPS (diluted) | $0.67 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $750.8M | ||
| Q4 25 | $1.3B | $4.6B | ||
| Q3 25 | $1.2B | $3.7B | ||
| Q2 25 | $1.2B | $3.7B | ||
| Q1 25 | $1.0B | $3.7B | ||
| Q4 24 | $1.1B | $4.8B | ||
| Q3 24 | $994.2M | $3.0B | ||
| Q2 24 | $1.0B | $4.3B |
| Q1 26 | $267.3M | $1.9M | ||
| Q4 25 | $267.3M | $517.0M | ||
| Q3 25 | $283.8M | $213.8M | ||
| Q2 25 | $179.8M | $406.2M | ||
| Q1 25 | $105.4M | $48.1M | ||
| Q4 24 | $151.7M | $905.4M | ||
| Q3 24 | $134.6M | $-220.0M | ||
| Q2 24 | $143.5M | $353.1M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
| Q1 26 | 21.2% | 0.3% | ||
| Q4 25 | 21.2% | 11.3% | ||
| Q3 25 | 23.5% | 5.8% | ||
| Q2 25 | 15.5% | 11.1% | ||
| Q1 25 | 10.2% | 1.3% | ||
| Q4 24 | 13.6% | 19.1% | ||
| Q3 24 | 13.5% | -7.3% | ||
| Q2 24 | 14.3% | 8.2% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $2.30 | ||
| Q3 25 | $0.70 | $0.95 | ||
| Q2 25 | $0.45 | $1.79 | ||
| Q1 25 | $0.27 | $0.21 | ||
| Q4 24 | $0.37 | $3.92 | ||
| Q3 24 | $0.34 | $-0.95 | ||
| Q2 24 | $0.35 | $1.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | — |
| Total Assets | $6.3B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $4.4B | ||
| Q3 25 | $1.8B | $5.1B | ||
| Q2 25 | $1.2B | $3.7B | ||
| Q1 25 | $904.9M | $3.9B | ||
| Q4 24 | $606.1M | $4.2B | ||
| Q3 24 | $621.2M | $6.2B | ||
| Q2 24 | $939.2M | $4.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.9B | ||
| Q3 25 | — | $3.9B | ||
| Q2 25 | — | $3.9B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | $3.9B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $11.9B | ||
| Q3 25 | $2.7B | $11.7B | ||
| Q2 25 | $2.6B | $11.4B | ||
| Q1 25 | $2.3B | $11.2B | ||
| Q4 24 | $2.1B | $11.1B | ||
| Q3 24 | $2.0B | $11.2B | ||
| Q2 24 | $2.4B | $11.0B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $341.4B | ||
| Q3 25 | $7.5B | $334.5B | ||
| Q2 25 | $7.3B | $323.1B | ||
| Q1 25 | $6.8B | $313.0B | ||
| Q4 24 | $6.5B | $313.7B | ||
| Q3 24 | $6.4B | $322.9B | ||
| Q2 24 | $6.8B | $308.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.39× | ||
| Q4 24 | — | 0.36× | ||
| Q3 24 | — | 0.35× | ||
| Q2 24 | — | 0.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
